Whole Body / General151 citations
J Mol Histol 56(1):29, 2024
Bioeffects Seen
Authors not listed · 2024
Insufficient information to determine key finding.
Plain English Summary
Summary written for general audiences
Insufficient information provided. Only a journal citation (J Mol Histol 56(1):29, 2024) is available without a title, abstract, or study details. Cannot determine if this is an EMF health effects study or summarize its findings.
Why This Matters
A complete study record requires at minimum a title and abstract to assess relevance to EMF research and to extract meaningful scientific findings.
Exposure Information
Specific exposure levels were not quantified in this study.
Cite This Study
Unknown (2024). J Mol Histol 56(1):29, 2024.
Show BibTeX
@article{j_mol_histol_56129_2024_ce2442,
author = {Unknown},
title = {J Mol Histol 56(1):29, 2024},
year = {2024},
doi = {10.15585/mmwr.mm7309a4},
}Quick Questions About This Study
This appears to be a database classification error. The study examines nirsevimab antibody effectiveness against respiratory syncytial virus in infants, with no electromagnetic field exposure component or EMF-related findings whatsoever.
No, nirsevimab is a monoclonal antibody injection given to prevent RSV infection in infants. The treatment mechanism involves immune system enhancement, not electromagnetic field exposure or wireless technology.
There is no scientific evidence connecting RSV vaccination with electromagnetic field sensitivity. This study focused solely on preventing respiratory infections and measured no EMF-related health outcomes or exposure parameters.
No electromagnetic frequencies were tested. This research evaluated a pharmaceutical intervention (nirsevimab antibody) for preventing RSV hospitalizations in infants during their first respiratory virus season from October 2023 to February 2024.
The 90% effectiveness refers to nirsevimab's ability to prevent RSV-related hospitalizations, not electromagnetic field protection. This pharmaceutical study outcome has no connection to EMF exposure reduction or wireless radiation shielding effectiveness.